Recombinant humanized monoclonal antibody targeting human gprc5d and application thereof
AssigneeSuzhou Dima Biotechnology Co., Ltd
InventorsDonghui MA, Kaikai ZENG, Antao HE, Shujuan HONG, Fen MEI
Life of this patent
Estimating the term…
Loading patent…
AssigneeSuzhou Dima Biotechnology Co., Ltd
InventorsDonghui MA, Kaikai ZENG, Antao HE, Shujuan HONG, Fen MEI
Estimating the term…
A specific recombinant humanized monoclonal antibody targeting human GPRC5D can be used in ELISA and flow detection methods, and can be used for diagnosis and treatment targeting GPRC5D protein. The monoclonal antibody comprises a heavy chain variable region and a light chain variable region, and the amino acid sequence and nucleotide sequence of the monoclonal antibody can be used alone or in double-stranded combination. In addition, the sequences of the specific recombinant humanized monoclonal antibody targeting human GPRC5D can be constructed into biological materials or preparations such as monoclonal antibodies, antibody conjugates, bispecific antibodies, CAR-immune cells, etc., and can be used for the diagnosis and treatment of GPRC5D-related diseases.
An antibody or an antigen-binding fragment thereof, comprising a heavy chain variable region, wherein the heavy chain variable region comprises the following CDRs:
(canceled)
Dependencies are inferred from the claim text.